July 13, 2023, 1:07 p.m. | Ingrid Lunden

TechCrunch techcrunch.com

Artificial intelligence has been a big theme in the world of health and medical research, and specifically in the area of drug discovery. Today, another hopeful in the space is announcing a funding round to expand its own contribution to the field. Causaly, a London startup that has built an AI platform to help researchers […]


Causaly, an AI platform for drug discovery and biomedical research, raises $60M by Ingrid Lunden originally published on TechCrunch

ai ai drug discovery ai platform artificial artificial intelligence big biomedical biotech & health causaly discovery drug discovery funding funding round health iconiq growth index ventures intelligence london medical medical research platform raises research space startup world

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US